Literature DB >> 22234841

Interleukin-1A -889C/T polymorphism and risk of Alzheimer's disease: a meta-analysis based on 32 case-control studies.

Xue Qin1, Qiliu Peng, Zhiyu Zeng, Zhiping Chen, Liwen Lin, Yan Deng, Xiamei Huang, Juanjuan Xu, Huiling Wu, Shan Huang, Shan Li, Jinmin Zhao.   

Abstract

The Interleukin-1A (IL-1A) -889C/T polymorphism has been reported to be associated with Alzheimer's disease (AD) susceptibility, but the results of these previous studies have been inconsistent. The aim of this study was to explore whether the IL-1A -889C/T polymorphism confers susceptibility to AD. All studies published up to July 2011 on the association between the IL-1A -889C/T polymorphism and AD risk were identified by searching electronic databases PubMed, Embase and Alzgene. The association between the IL-1A -889C/T polymorphism and AD risk was assessed by odds ratios (ORs) together with their 95% confidence intervals (CIs). A total of 32 case-control studies including 7,046 AD cases and 7,534 controls were eventually identified. Overall, positive associations of the IL-1A -889C/T polymorphism with AD risk were found in allele comparison T versus C (OR = 1.019, 95% CI= 1.027-1.198), recessive model TT versus CT + CC (OR = 1.278, 95% CI = 1.073-1.522) and dominant model TT + CT versus CC (OR = 1.102, 95% CI = 1.013-1.200). In subgroup analysis stratified by ethnicity, significant associations were demonstrated in Caucasians but not in Asians. In subgroup analysis according to the age of onset, no significant association was detected. The present meta-analysis suggests that the IL-1A is a candidate gene for AD susceptibility. The IL-1A -889C/T889C/T polymorphism may be a risk factor for AD in Caucasians. Further investigations taking the APOE ε4 status and other confirmed genetic factors and potential gene-gene and gene-environmental interactions into consideration for this polymorphism should be conducted.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22234841     DOI: 10.1007/s00415-011-6381-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  54 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Association of an interleukin 1B gene polymorphism (-511) with Parkinson's disease in Finnish patients.

Authors:  K M Mattila; J O Rinne; T Lehtimäki; M Röyttä; J P Ahonen; M Hurme
Journal:  J Med Genet       Date:  2002-06       Impact factor: 6.318

3.  A method for meta-analysis of molecular association studies.

Authors:  Ammarin Thakkinstian; Patrick McElduff; Catherine D'Este; David Duffy; John Attia
Journal:  Stat Med       Date:  2005-05-15       Impact factor: 2.373

4.  Interaction between dopamine beta-hydroxylase and interleukin genes increases Alzheimer's disease risk.

Authors:  I Mateo; J Infante; E Rodríguez; J Berciano; O Combarros; J Llorca
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

5.  Association between interleukin-1A polymorphism and cerebral amyloid angiopathy-related hemorrhage.

Authors:  M O McCarron; J Stewart; P McCarron; S Love; H V Vinters; J W Ironside; D M A Mann; D I Graham; J A R Nicoll
Journal:  Stroke       Date:  2003-08-28       Impact factor: 7.914

Review 6.  Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression.

Authors:  W S Griffin; J G Sheng; M C Royston; S M Gentleman; J E McKenzie; D I Graham; G W Roberts; R E Mrak
Journal:  Brain Pathol       Date:  1998-01       Impact factor: 6.508

7.  Interleukin-1 gene cluster polymorphisms and risk of Alzheimer's disease in Chinese Han population.

Authors:  X-Q Li; J-W Zhang; Z-X Zhang; D Chen; Q-M Qu
Journal:  J Neural Transm (Vienna)       Date:  2004-05-12       Impact factor: 3.575

8.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

Authors:  W S Griffin; L C Stanley; C Ling; L White; V MacLeod; L J Perrot; C L White; C Araoz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.

Authors:  A Drzezga; T Grimmer; G Henriksen; M Mühlau; R Perneczky; I Miederer; C Praus; C Sorg; A Wohlschläger; M Riemenschneider; H J Wester; H Foerstl; M Schwaiger; A Kurz
Journal:  Neurology       Date:  2009-04-01       Impact factor: 9.910

10.  Lack of association between interleukin-1alpha polymorphism and Alzheimer disease or vascular dementia.

Authors:  Yu-Min Kuo; Pao-Chi Liao; Chingju Lin; Chih-Wei Wu; Hsueh-Meei Huang; Chih-Chien Lin; Liang-Jen Chuo
Journal:  Alzheimer Dis Assoc Disord       Date:  2003 Apr-Jun       Impact factor: 2.703

View more
  6 in total

Review 1.  Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases.

Authors:  Julia Doroszkiewicz; Magdalena Groblewska; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2022-04-21       Impact factor: 6.208

Review 2.  Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms.

Authors:  Fan Su; Feng Bai; Zhijun Zhang
Journal:  Neurosci Bull       Date:  2016-08-27       Impact factor: 5.203

3.  Association Between Interleukin-1A, Interleukin-1B, and Bridging integrator 1 Polymorphisms and Alzheimer's Disease: a standard and Cumulative Meta-analysis.

Authors:  Xiaoliu Dong; Li Zhang; Qingling Meng; Qiuyan Gao
Journal:  Mol Neurobiol       Date:  2016-01-15       Impact factor: 5.590

4.  Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein.

Authors:  Anna Zettergren; Kina Höglund; Silke Kern; Valgeir Thorvaldsson; Msc Johan Skoog; Oskar Hansson; Niels Andreasen; Nenad Bogdanovic; Kaj Blennow; Ingmar Skoog; Henrik Zetterberg
Journal:  Sci Rep       Date:  2019-02-21       Impact factor: 4.379

5.  Polymorphisms of Proinflammatory Cytokines in Relation to APOE Epsilon 4 and Risk of Alzheimer's Disease in the Lithuanian Population.

Authors:  Greta Pšemeneckienė; Kęstutis Petrikonis; And Daiva Rastenytė
Journal:  Medicina (Kaunas)       Date:  2019-10-15       Impact factor: 2.430

Review 6.  Inflammation in the CNS: Understanding Various Aspects of the Pathogenesis of Alzheimer's Disease.

Authors:  Julia Doroszkiewicz; Piotr Mroczko; Agnieszka Kulczyńska-Przybik
Journal:  Curr Alzheimer Res       Date:  2022       Impact factor: 3.040

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.